Showing results 631-640 / 1463
Half year results for the six months ended 30th September 2017
News: Strong operational momentum continued and full year outlook confirmed.
ExploreJM’s Chief Executive attends Global Hydrogen Leaders Forum
News: The Hydrogen Council came together in San Francisco on Thursday for its third annual CEO event to engage with stakeholders and drive large scale commercialisation of hydrogen worldwide.
ExploreJM's latest ATR technology licence underway
News: Johnson Matthey’s latest ATR technology licence underway after Methanex reaches final investment decision for Geismar 3 plant.
ExploreJM joins over 60 UK business leaders to sign letter demanding action on black inclusion
News: More major UK business leaders have signed an open letter which demands action now for #blacklivesmatter with agreed actions for clear and positive change.
ExploreHalf year results for the six months ended 30th September 2014
Half year results for the six months ended 30th September 2014
ExploreJohnson Matthey Signs MOU with Chinese Academy of Sciences Holdings Co., Ltd.
The memorandum allows for broad collaboration with the Academy, which is China's top science and technology research and educational organisation
ExploreJohnson Matthey partners with Immunomedics to develop life-saving cancer treatment
News: Johnson Matthey has announced a strategic manufacturing partnership for the large-scale production of the drug-linker used in Immunomedics’ lead antibody-drug conjugate.
ExploreStanding with Mexico - JM offers earthquake support
News: Johnson Matthey will be making a donation of 8,000 US dollars to the Mexican Red Cross, a charity partner selected by our colleagues in Mexico.
Explore